Novartis Receives European Commission Approval To Acquire Chiron
Filed in archive Corporate and Industrial News on February 7, 2006
Novartis announced yesterday that the European Union antitrust regulators approved of its takeover of Chiron Corp. When I first blogged about the takeover here in this weblog, I thought it was a done deal. I didn't realize there were issues to be settled with the European Commission. Oh well, seems all that's cleared up now.
A monthlong European Commission investigation found "little or no overlaps exist between Novartis' and Chiron's product ranges,'' the EU head office said in a statement, adding that there was little potential competition overlaps between the two companies.
Novartis is paying $5.1 billion for the 58 percent of the Emeryville, Calif.-based company it doesn't already control.
Read more from Novartis or from SiliconValley.com.
Novartis is paying $5.1 billion for the 58 percent of the Emeryville, Calif.-based company it doesn't already control.
Tags: novartis chiron biotech european commission european+commission novartis+receives acquire+chiron
Vote for Novartis Receives European Commission Approval To Acquire Chiron:
|
Rating: 7.00 out of 2 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells